Antiproteinuric Effect of SGLT2 Inhibitors in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
Anticancer Research · 2026
DOI: 10.21873/anticanres.18360 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Anticancer Research, 2026. Verfasst von Tomoki Hori und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Nara Prefecture General Medical Center, Nara, Japan. Hauptthemen laut MEDLINE: Bevacizumab, Carcinoma, Hepatocellular, Liver Neoplasms, Proteinuria.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Nara Prefecture General Medical Center, Nara, Japan.
- Department of Pharmacy, Kobe University Hospital, Kobe, Japan.
- Department of Pharmacy, Kobe University Hospital, Kobe, Japan; yamakz@okayama-u.ac.jp.
- Department of Integrated Clinical and Basic Pharmaceutical Science, Okayama University, Okayama, Japan.
- Department of Pharmacy, Nara Medical University Hospital, Nara, Japan.
- Department of Pharmacy, Tenri Hospital, Tenri, Japan.
Zitieren
APA
Hori, T., Yamamoto, K., Aoi, H., Koizumi, Y., Kuromatsu, M., Fukui, A., Okamoto, H., Hirata, A., Shinmori, K., Imanaka, Y., Namba, M., Kitamura, S., Nakanishi, K., Tsushima, H., Yano, I., Moriya, K., Matsui, M., & Ikushima, S. (2026). Antiproteinuric Effect of SGLT2 Inhibitors in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab. Anticancer Research. https://doi.org/10.21873/anticanres.18360
Vancouver
Hori T, Yamamoto K, Aoi H, Koizumi Y, Kuromatsu M, Fukui A, et al. Antiproteinuric Effect of SGLT2 Inhibitors in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab. Anticancer Research. 2026. doi:10.21873/anticanres.18360
BibTeX
@article{Hori2026,
author = {Hori, Tomoki and Yamamoto, Kazuhiro and Aoi, Hiroshi and Koizumi, Yusuke and Kuromatsu, Makoto and Fukui, Aiko and Okamoto, Hiroyo and Hirata, Atsushi and Shinmori, Kentaro and Imanaka, Yuki and Namba, Miyu and Kitamura, Syunsuke and Nakanishi, Keisuke and Tsushima, Hideo and Yano, Ikuko and Moriya, Kei and Matsui, Masaru and Ikushima, Shigeki},
title = {Antiproteinuric Effect of SGLT2 Inhibitors in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18360}
}
EUVIMED